SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Conditional placing and proposed board changes

23 Nov 2018 12:07

RNS Number : 3630I
Sabien Technology Group PLC
23 November 2018
 

For immediate release

23 November 2018

 

Sabien Technology Group plc

 ("Sabien" or the "Company")

Conditional Placing to raise £400,000, proposed Board changes and General Meeting

 

Further to recent announcements, the Board of Sabien has continued to focus on the conversion of sales pipeline opportunities, including rental opportunities; conversion of Forensic Boiler Audit opportunities; and further non-staff cost reduction to improve Sabien's profitability. But as first announced on 6 August 2018, the Group has, to date, been unable to accelerate the current rate of pipeline conversion which has been slower than expected. As a result, the previously announced target of monthly break-even will not be achieved by December 2018, requiring the Group to raise additional equity. 

 

To address this requirement, Sabien announces that the Company's broker, Peterhouse Capital Limited, has today conditionally raised gross proceeds of £400,000 via the placing of 400,000,000 new ordinary shares (the "Placing Shares") with new and existing investors, at a price of 0.1 pence per Placing Share (the "Placing Price"). The Placing is conditional, inter alia, on the approval of the resolutions effecting a proposed subdivision by the Company's shareholders at a General Meeting.

 

Once issued, the Placing shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Placing Shares to be admitted to trading on AIM ("Admission") and a further announcement will be made in due course to confirm the date on which this is expected to become effective.

 

The Placing has been undertaken with both existing and new shareholders, including Mr Chris Akers, who has subscribed for 100,000,000 Placing Shares which will represent 16.9% of the enlarged share capital of the Company, post-Placing.

 

The proceeds of the Placing will be used to provide additional working capital for the Company and in particular, to support activities to generate orders from the sales pipeline outlined in the Trading Update published on 6 August 2018 and to allow the Board the ability to evaluate additional acquisition and investment opportunities to enhance the long-term value of the Company for shareholders.

The Board is acutely aware that the Placing is dilutive for the existing shareholders and has considered whether any pre-emptive offering might be possible but has concluded that it was neither practicable nor cost effective to do so at this time given the current need to raise additional funds, the working capital requirements of the Company and current market conditions.

 

Proposed Subdivision of ordinary shares and General Meeting

The Placing Price is less than the current nominal value of its existing ordinary shares of 0.5 pence. The UK Companies Act 2006 (as amended) prohibits the Company from issuing ordinary shares at a price below the nominal value. Accordingly, it will be necessary for the Company to carry out a subdivision of the existing ordinary shares whereby each existing ordinary share will be subdivided into one new ordinary share of 0.01 pence (the "New Ordinary Shares") and one deferred share of 0.49 pence (the "Subdivision") to enable the Placing to become unconditional. The New Ordinary Shares will continue to carry the same rights as attached to the existing ordinary shares, save for the reduction in nominal value.

 

The Company will shortly be posting details of a General Meeting to its shareholders at which shareholders will be asked to approve the Subdivision (the "General Meeting"). The Placing is conditional on the approval of the resolutions effecting the Subdivision by the Company's shareholders at the General Meeting.

 

Proposed Board Changes

The Directors expect that immediately following the General Meeting and subject to satisfactory completion of standard regulatory and other checks in compliance with the AIM Rules, John Taylor will be appointed to the Board as a Non-executive Director. The Board anticipates making additional new Board appointments in due course.

 

Mr Taylor works with a group who assist small cap technology stocks with their development. Prior to that he spent eighteen months working in private equity backed portfolio companies, driving operational turnaround initiatives and implementing costing systems. He also spent over 20 years in the Army Air Corps, leaving in 2015 with the rank of colonel. Between 2013 and 2015 he was senior strategic communications officer for the Ministry of Defence. He joined the Board of Kin Group plc (subsequently renamed Bidstack Group plc) in November 2017.

 

In addition, on completion of the Placing, Mr Bruce Gordon, Chairman of the Company will step down from the Board of the Company to focus on other business ventures. The Company would like to thank Mr Gordon for his contribution to the Company over the years would like to wish him every success in his future endeavours.

 

Further AIM disclosures relating to Mr Taylor's proposed appointment

Further disclosures on Mr Taylor as required under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies are as follows. John Edward Taylor (age 46), has held the following directorships and/or partnerships in the past five years:

 

Current:

Past:

Ugly Panda LLP

Bidstack Group plc (formerly known as Kin Group plc)

AS Group Ventures Inc

 

 

n.a.

As at the date of this announcement, Mr Taylor has subscribed for 5,000,000 Placing Shares at the Placing Price. Subject to satisfactory completion of standard regulatory and other checks in compliance with the AIM Rules, Mr Taylor will join the Board. Pending completion of such checks, there is currently no further information that the Company is aware of to be disclosed in relation to Mr Taylor's appointment pursuant to AIM Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

Special note concerning the Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR"). Market soundings, as defined in MAR, were taken in respect of the Placing, with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

The person who arranged for the release of this announcement on behalf of the Company was Alan O'Brien, CEO and Director.

 

For further information:

 

Sabien Technology Group plc

Alan O'Brien

+44(0)20 7993 3700

Beaumont Cornish Limited (Nominated Advisor)

Michael Cornish and Roland Cornish

www.beaumontcornish.com

+44(0)20 7628 3396

Peterhouse Capital Limited (Broker)

Martin Lampshire and Fungai Ndoro

+44(0)20 7469 0930

 

 

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFELFEDFASESF
Date   Source Headline
11th Jun 20267:00 amRNSIssue of shares to directors & broker
2nd Jun 20267:00 amRNSProposed balance sheet strengthening & M2G update
29th May 20265:00 pmRNSTotal Voting Rights
21st May 20267:00 amRNSProposed Commercial Partnership & Investment
20th May 20266:22 pmRNSSettlement of Historical Contract
31st Mar 20267:00 amRNSHalf-year Report for the 6 months to 31 Dec 2025
10th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Jan 20265:30 pmRNSHolding(s) in Company
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
9th Dec 20251:20 pmRNSResult of Annual General Meeting
9th Dec 20257:00 amRNSAGM Statement & Trading Update
19th Nov 20257:00 amRNSProposed Strategic Agreement with COF
13th Nov 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
10th Nov 20257:00 amRNSNew Factoring Facility
5th Nov 202512:01 pmRNSAppointment of Corporate Broker
2nd Oct 202512:06 pmRNSFurther update on Sabien, b.grn & related matters
19th Sep 20257:00 amRNSTrading Update
31st Jul 20254:59 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSYear End Trading Update
30th Jun 20252:53 pmRNSIssue of shares to directors
23rd Jun 20254:28 pmRNSHolding(s) in Company
17th Mar 20257:00 amRNSHalf-year Report for the 6 months to 31 Dec 2024
6th Feb 202511:43 amRNSUpdate in relation to Aeristech Limited
27th Jan 20257:00 amRNSTrading update - acceleration of new M2G orders
31st Dec 202412:30 pmRNSTotal Voting Rights
19th Dec 202410:51 amRNSResult of Annual General Meeting
19th Dec 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
28th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSIssue of shares to non-executive directors
18th Nov 20247:00 amRNSFinal Results & Annual Report & Accounts for 2024
11th Nov 20247:00 amRNSNew M2G Cloud Connection System Order
17th Oct 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
30th Sep 20245:00 pmRNSTotal Voting Rights
26th Sep 20244:21 pmRNSDirector/PDMR Shareholding
19th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:30 pmRNSAdmission of New Shares & Total Voting Rights
29th Aug 20244:00 pmRNSUpdate on Admission of New Ordinary Shares
20th Aug 20247:00 amRNSRelated Party Funding
8th Jul 20248:15 amRNSTrading Statement
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.